Microbiology & Infectious Diseases

Cord blood biomarkers may help detect early neonatal sepsis, improving diagnosis and reducing unnecessary antibiotic use in preterm infants.

A major global study confirms that malaria resistance diminishes IPTp-SP’s antimalarial benefits but not its impact on low birthweight, prompting urgent calls for new preventive strategies.

WHO has endorsed injectable lenacapavir as a twice-yearly HIV prevention tool, offering new hope for communities facing high infection risks and adherence barriers.

Outbreak response vaccinations have prevented 5.81 million cases and saved USD 31 billion in LMICs since 2000.

Delpazolid and sutezolid show strong efficacy and reduced toxicity in Phase 2 TB trials, offering safer alternatives to linezolid for drug-resistant TB treatment.

A UKHSA survey finds strong vaccine confidence among UK parents, with 87% trusting vaccine effectiveness and satisfaction high in NHS delivery and communication.

French researchers report distinct fungal species in intravenous drug users with yeast fungaemia, suggesting the need for tailored care strategies.

Global vaccine coverage has improved since 1980 but stalled and declined during COVID-19, with millions of zero-dose children concentrated in a few countries, risking setbacks to immunisation goals.